How should the estradiol 208 pg/mL, progesterone 1.2 ng/mL, follicle‑stimulating hormone 8.8 IU/L, and luteinizing hormone 3.5 IU/L results be interpreted in a 48‑year‑old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormone Interpretation in a 48-Year-Old Woman

These hormone levels indicate a perimenopausal transition with evidence of diminished ovarian reserve but preserved follicular activity, and the low progesterone suggests either anovulation or measurement outside the mid-luteal phase. 1

Key Findings Analysis

FSH Elevation Signals Perimenopause

  • The FSH of 8.8 IU/L, while below the classic menopausal threshold, is elevated for a reproductive-age woman and indicates diminished ovarian reserve. 1
  • FSH >10 IU/L definitively indicates diminished ovarian reserve, but levels between 8-10 IU/L in women over 40 years represent early decline. 1
  • Research demonstrates that FSH rises progressively in the years preceding menopause (starting in the early 40s), while LH remains relatively normal—exactly the pattern seen here with FSH 8.8 and LH 3.5. 2, 3

Estradiol Remains Adequate

  • The estradiol of 208 pg/mL (approximately 763 pmol/L) is within normal follicular phase range (51-601 pg/mL) and indicates maintained ovarian estrogen production despite declining follicular reserve. 4
  • This preserved estradiol despite elevated FSH is characteristic of the perimenopausal transition, where remaining follicles continue to produce estrogen even as their numbers decline. 2, 3
  • Estradiol below 20 pg/mL would suggest premature ovarian insufficiency, but this patient's level is nearly 10-fold higher, ruling out that diagnosis. 4

Progesterone Interpretation Requires Timing Context

  • The progesterone of 1.2 ng/mL (approximately 3.8 nmol/L) is below the ovulatory threshold of 6 nmol/L, indicating either anovulation or measurement during the follicular phase rather than mid-luteal phase. 1
  • Mid-luteal progesterone (measured 7 days after suspected ovulation) is the only reliable hormonal indicator of ovulation. 1
  • Without knowing the cycle day of measurement, this low progesterone cannot definitively confirm anovulation—it may simply reflect follicular phase timing. 1
  • Perimenopausal women commonly experience declining luteal progesterone even with continued ovulation, as demonstrated in women aged 40-50 years. 2

LH:FSH Ratio Assessment

  • The LH:FSH ratio is 0.4 (3.5/8.8), which is inverted from the typical reproductive-age pattern and rules out PCOS (which requires LH:FSH >2). 1
  • This inverted ratio with relatively higher FSH than LH is pathognomonic for the perimenopausal transition. 3

Clinical Significance at Age 48

This 48-year-old woman is in active perimenopause with:

  • Declining but not depleted ovarian reserve (FSH approaching but not exceeding 10 IU/L)
  • Maintained estrogen production from remaining follicles
  • Possible anovulatory cycles or irregular ovulation (based on low progesterone if measured appropriately)
  • Expected hormonal pattern for her age, as FSH elevation begins several years before final menstrual period 2, 3

Critical Next Steps

Confirm Ovulatory Status

  • Repeat progesterone measurement specifically during mid-luteal phase (cycle day 21 for 28-day cycles, or 7 days after suspected ovulation) to definitively assess ovulation. 1
  • Progesterone ≥6 nmol/L confirms ovulation occurred; <6 nmol/L indicates anovulation. 1

Monitor Menstrual Pattern

  • Document cycle length and regularity, as increasing cycle variability is characteristic of perimenopause. 3
  • Cycles may alternate between ovulatory and anovulatory, with variable estrogen withdrawal bleeding. 3

Additional Evaluation if Symptomatic

  • Assess for vasomotor symptoms (hot flashes), sleep disturbance, or vaginal dryness that may warrant hormone therapy consideration. 5
  • Check thyroid function (TSH) and prolactin if menstrual irregularities are present, as these can mimic perimenopausal patterns. 1

Common Pitfalls to Avoid

  • Do not diagnose menopause based on a single FSH measurement—FSH can fluctuate significantly during perimenopause, and definitive menopause requires 12 months of amenorrhea. 3
  • Do not interpret progesterone without knowing precise cycle timing—random progesterone measurements are meaningless for assessing ovulation. 1
  • Do not assume fertility is absent—ovulation may still occur intermittently during perimenopause, and contraception remains necessary if pregnancy is undesired. 3
  • Avoid measuring hormones in women using hormonal contraceptives, as these suppress the pituitary-ovarian axis and render results uninterpretable. 1

References

Guideline

Hormonal Indicators of Ovulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Estrogen Levels in Premenopausal Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Which hormonal laboratory tests should be ordered to evaluate a woman's endocrine status?
Is hormone testing recommended twice during her menstrual cycle?
What is the diagnosis and treatment for a 48-year-old female patient with elevated Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) levels, hyperphosphatasemia (alkaline phosphatase of 135), low total estrogen, and low progesterone?
Can a patient undergo Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), progesterone, estradiol, prolactin, and Thyroid-Stimulating Hormone (TSH) testing?
What tests should be ordered to assess a female's hormone levels?
In a 74-year-old woman with hypertriglyceridemia (triglycerides 354 mg/dL), which is the safer and more effective treatment: fenofibrate or ezetimibe (Zetia)?
What intravenous fluid composition and dosing should be used to treat a ketotic patient (e.g., early diabetic ketoacidosis, starvation ketosis, or hypoglycemia with elevated ketones) to suppress ketogenesis while avoiding hyperglycaemia?
How should a 50-year-old woman with a history of glioblastoma who presents two weeks after a deep dental cleaning with right-side facial tenderness, a sensation of swelling, and right-ear pain be managed?
How should I manage orthostatic hypotension in an older adult with heart failure who is taking furosemide (Bumex), spironolactone, metoprolol, and amiodarone?
How should transient dysesthesia of the infrapatellar branch of the saphenous nerve be managed?
How should rapid‑acting bolus insulin be titrated in a 70‑kg insulin‑naïve adult with type 1 or type 2 diabetes starting a basal‑bolus regimen using pre‑meal and post‑prandial glucose values?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.